150 results
Keyword epoetin Remove keyword
Exclude documents
Exclude documents Remove Exclude documents filter
-
List item
Press release: European Medicines Agency finalises set of guidelines on similar biological medicines and publishes two more new concept papers
Last updated: 08/03/2006for medicines containing epoetin will also be available shortly … for medicines containing epoetin will also be available shortly … -
List item
Human medicines highlights: Issue 27 - April 2011
Epostim ( epoetin alfa ) Intended for the treatment …
-
List item
News: Are you an SME interested in funding of Adverse Drug Reaction research through the European Commission's 7th Framework Programme?
Last updated: 27/07/2010pancreatitis/pancreatic cancer. • Epoetins: Risk of tumour growth progression … for drug safety research: Epoetins and tumour progression, shortened … -
List item
Human medicine European public assessment report (EPAR): Aranesp
Date of authorisation: 08/06/2001, Revision: 41, Authorised, Last updated: 14/05/2019patients who were administered epoetin alfa (Leyland-Jones B, 2003 … Leyland-Jones B, 2003) or epoetin beta (Henke M et al, 2003 … with cancer treated with epoetins. Further to the recommendations … -
List item
Human medicine European public assessment report (EPAR): Elaprase (updated)
Date of authorisation: 08/01/2007,
, 
, 
, Revision: 19, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Tamiflu (updated)
Date of authorisation: 20/06/2002, Revision: 37, Authorised, Last updated: 20/11/2019methoxy polyethylene glycol-epoetin beta), Pegasys (peginterferon … methoxy polyethylene glycol-epoetin beta, used for the treatment … -
List item
Human medicine European public assessment report (EPAR): Xeloda
Date of authorisation: 02/02/2001, Revision: 24, Authorised, Last updated: 28/08/2019methoxy polyethylene glycol-epoetin beta), Pegasys (peginterferon … methoxy polyethylene glycol-epoetin beta, used for the treatment … -
List item
Human medicine European public assessment report (EPAR): Pegasys
Date of authorisation: 20/06/2002, Revision: 37, Authorised, Last updated: 07/10/2019methoxy polyethylene glycol-epoetin beta), Pegasys (peginterferon … methoxy polyethylene glycol-epoetin beta, used for the treatment … -
List item
Human medicine European public assessment report (EPAR): Xenical
Date of authorisation: 29/07/1998, Revision: 23, Authorised, Last updated: 22/01/2019methoxy polyethylene glycol-epoetin beta), Pegasys (peginterferon … methoxy polyethylene glycol-epoetin beta, used for the treatment … -
List item
Human medicine European public assessment report (EPAR): Jakavi
Date of authorisation: 23/08/2012, Revision: 17, Authorised, Last updated: 28/08/2019 -
List item
Human medicine European public assessment report (EPAR): Alli (previously Orlistat GSK)
Date of authorisation: 22/07/2007, Revision: 16, Authorised, Last updated: 04/12/2018methoxy polyethylene glycol-epoetin beta), Pegasys (peginterferon … methoxy polyethylene glycol-epoetin beta, used for the treatment … -
List item
Human medicine European public assessment report (EPAR): Nespo
Date of authorisation: 08/06/2001, Revision: 19, Withdrawn, Last updated: 28/01/2009 -
List item
Human medicine European public assessment report (EPAR): Rubraca
Date of authorisation: 23/05/2018,, 
, Revision: 3, Authorised, Last updated: 24/05/2019
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 July 2012
CHMP, Last updated: 20/07/2012methoxy polyethylene glycol-epoetin beta, peginterferon alfa-2a … -
List item
Withdrawn application: Aranesp
darbepoetin alfa, date of withdrawal: 21/02/2018, Post-authorisation, Last updated: 24/04/2018 -
List item
Withdrawn application: Omontys
peginesatide, date of withdrawal: 28/06/2013, Initial authorisation, Last updated: 28/06/2013with another medicine called epoetin. The main measure of effectiveness … -
List item
Withdrawn application: Orathecin
Rubitecan, date of withdrawal: 19/01/2006, Initial authorisation, Last updated: 23/01/2006 -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)20-23 June 2011
CHMP, Last updated: 24/06/2011neuropathy. Retacrit (epoetin zeta), from Hospira UK Ltd … epoetin zeta), from Hospira UK Ltd … -
List item
Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)
daclatasvir / dasabuvir / sofosbuvir / ledipasvir / simeprevir / ombitasvir/paritaprevir / ritonavir, ?> associated names: Sovaldi, Olysio, Viekirax, Harvoni, Exviera, Daklinza, Article 20 procedures
Status: European Commission final decision, opinion/position date: 15/12/2016, EC decision date: 23/02/2017, -
List item
Opinion/decision on a Paediatric investigation plan (PIP):
Decision type: PM: decision on the application for modification of an agreed PIP, PIP number: EMEA-001557-PIP01-13-M03, decision date: 17/04/2019, Last updated: 31/01/2019, compliance check: Xthe European Union, such as Epoetin alfa, that are known to work … -
List item
PRAC recommendations on safety signals
Last updated: 30/09/2019 -
List item
PRAC: Agendas, minutes and highlights
Last updated: 14/06/2019 -
List item
CHMP: Agendas, minutes and highlights
Last updated: 28/01/2019 -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 September 2018
European Medicines Agency, London, UK, from 17/09/2018 to 20/09/2018, Last updated: 31/10/2018 -
List item
PRAC: meeting archive 2012-2013